Skip to main content
NexgenRx Inc. (TSXV: NXG)
Canada flag Canada · Delayed Price · Currency is CAD
0.250
0.00 (0.00%)
Dec 19, 2024, 9:30 AM EST

NexgenRx Revenue

NexgenRx had revenue of 4.16M CAD in the quarter ending September 29, 2024, with 22.67% growth. This brings the company's revenue in the last twelve months to 16.11M, up 18.00% year-over-year. In the year 2023, NexgenRx had annual revenue of 13.85M with 8.33% growth.

Revenue (ttm)
16.11M
Revenue Growth
+18.00%
P/S Ratio
1.10
Revenue / Employee
805.50K
Employees
20
Market Cap
17.78M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 30, 202313.85M1.07M8.33%
Dec 30, 202212.78M939.94K7.94%
Dec 30, 202111.84M1.27M12.01%
Dec 30, 202010.57M1.03M10.82%
Dec 30, 20199.54M2.37M33.06%
Dec 30, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 30, 2016 Pro Pro Pro
Dec 30, 2015 Pro Pro Pro
Dec 30, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch + Lomb Corporation 6.33B
Bausch Health Companies Inc. 12.80B
WELL Health Technologies Corp. 957.69M
dentalcorp Holdings Ltd. 1.51B
Tilray Brands, Inc. 1.10B
Curaleaf Holdings, Inc. 1.83B
Sienna Senior Living Inc. 867.55M
Cronos Group Inc. 150.26M
Revenue Rankings

NexgenRx News

More News